Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both classical and L-type atypical BSE from cattle can infect goats with different incubation times, and tests can distinguish between the two strains.

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

The document concludes that there is hope for future psychopharmacology research despite challenges in treating schizophrenia.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Platelet-rich plasma therapy shows promise for hair regrowth in alopecia patients.

The mouse models are effective for testing new hair loss treatments.

Ethosomes are a promising way to deliver drugs through the skin.

Albizia saponaria bark ethanol extract, particularly at 15%, promotes hair growth in rabbits.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Lipid nanocarriers could effectively promote hair regrowth with fewer side effects.

EH-MSCs may help treat hair loss by reducing inflammation.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

The polyherbal hair tonic promotes hair growth and has antibacterial properties.

Bacopa monniera promotes hair growth, enhances memory, and helps with inflammation and stomach issues.

PRP can improve hair growth in androgenetic alopecia, but results vary.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

No cure exists for alopecia areata, and treatments are personalized.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.